Federated Hermes’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,522
| Closed | -$10.3K | – | 2201 |
|
|
2024
Q2 | $10.3K | Buy |
4,522
+2,490
| +123% | +$9.51K | ﹤0.01% | 1773 |
|
|
2024
Q1 | $8.78K | Buy |
2,032
+613
| +43% | +$2.14K | ﹤0.01% | 1792 |
|
|
2023
Q4 | $4.33K | Sell |
1,419
-1,855
| -57% | -$3.49K | ﹤0.01% | 1867 |
|
|
2023
Q3 | $4.71K | Buy |
+3,274
| New | +$6.34K | ﹤0.01% | 1890 |
|
|
2022
Q3 | – | Sell |
-179,472
| Closed | -$887K | – | 2269 |
|
|
2022
Q2 | $887K | Buy |
179,472
+139,872
| +353% | +$775K | ﹤0.01% | 1188 |
|
|
2022
Q1 | $301K | Buy |
39,600
+13,084
| +49% | +$124K | ﹤0.01% | 1540 |
|
|
2021
Q4 | $271K | Sell |
26,516
-33,617
| -56% | -$428K | ﹤0.01% | 1594 |
|
|
2021
Q3 | $807K | Buy |
+60,133
| New | +$980K | ﹤0.01% | 1363 |
|
|
2021
Q1 | – | Sell |
-25,188
| Closed | -$453K | – | 2365 |
|
|
2020
Q4 | $453K | Sell |
25,188
-398,023
| -94% | -$5.95M | ﹤0.01% | 1537 |
|
|
2020
Q3 | $4.89M | Buy |
423,211
+234,045
| +124% | +$3.86M | 0.01% | 733 |
|
|
2020
Q2 | $4.59M | Buy |
189,166
+141,296
| +295% | +$2.34M | 0.01% | 738 |
|
|
2020
Q1 | $528K | Buy |
+47,870
| New | +$894K | ﹤0.01% | 1360 |
|
|
2019
Q4 | – | Sell |
-20,015
| Closed | -$456K | – | 2323 |
|
|
2019
Q3 | $456K | Buy |
20,015
+18,183
| +993% | +$573K | ﹤0.01% | 1466 |
|
|
2019
Q2 | $56K | Sell |
1,832
-207
| -10% | -$4.36K | ﹤0.01% | 1661 |
|
|
2019
Q1 | $34K | Buy |
2,039
+1,011
| +98% | +$19.2K | ﹤0.01% | 1697 |
|
|
2018
Q4 | $20K | Sell |
1,028
-74,048
| -99% | -$2.77M | ﹤0.01% | 1775 |
|
|
2018
Q3 | $3.93M | Buy |
75,076
+21,217
| +39% | +$1.16M | 0.01% | 879 |
|
|
2018
Q2 | $2.34M | Buy |
+53,859
| New | +$2.31M | 0.01% | 948 |
|
Federated Hermes's GTHX Position: Q3 2024 in Review
Federated Hermes sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 4,522 shares — an estimated $10.3K sold.
Federated Hermes first reported a position in GTHX in Q2 2018 and held it in 18 quarters. The position peaked at $4.89M in Q3 2020. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.
- Federated Hermes reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Federated Hermes sold 4,522 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $10.3K.
- Federated Hermes first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2018 and held it in 18 quarters.
- Federated Hermes's G1 Therapeutics, Inc. Common Stock position peaked at $4.89M in Q3 2020.
- 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.
Based on Federated Hermes's 13F filing for Q3 2024, filed 13 Nov 2024.